Glucose
Recent studies show that a new drug improves glucose and
lipids in diabetes. An investigational drug called ragaglitazar
delivers a double benefit for people with type 2 diabetes: it
controls blood glucose while it improves the lipid profile, researchers
report. The study appeared in the June 2004 issue of Diabetes
Care. (7/04)
Insulin
Recent studies show that a short course of insulin
therapy may help people newly diagnosed with type 2 diabetes avoid this
therapy later. The new findings, which appear in the May 2004
medical journal Diabetes Care are based on a study of 16 patients
with newly diagnosed type 2 diabetes who were treated with intensive
insulin therapy for 2 to 3 weeks. At 1-year follow-up, only one
patient required insulin, while the rest were able to control their
sugar levels with diet or pills. (7/04)
|